- Home /
- CP Reports
CP Reports
Welcome to the home of CP Reports, we are the only publisher of life science deal term reports in the industry.
We offer over 200 report titles that focus upon different deal types from co-promotion to distribution, all of which provide you with an insight into the latest life science deal making trends.
Browse our reports by type to find your ideal match.
- Deal type reports
- Industry sector reports
- Stage partnered reports
- Technology reports
- Therapy reports
Our reports are updated regularly and include full coverage of all the deals made in the chosen report type.
Unsure which report to select? contact our report analysts who will assist your decision.
-
Global Vaccine Partnering Terms and Agreements 2010-2018: Deal trends, players and financials
$2,995.00Publication date: Nov 2018 | Publisher: Current Partnering
The Global Vaccine Partnering Terms and Agreements 2010-2018: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.
Learn More -
Global Antibody Partnering Terms and Agreements 2010-2018: Deal trends, players and financials
$2,995.00Publication date: Nov 2018 | Publisher: Current Partnering
The Global Antibody Partnering Terms and Agreements 2010-2018 report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare companies.
Learn More -
Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2012-2018: Deal trends, players, financials and forecasts
$2,995.00Publication date: Nov 2018 | Publisher: Current Partnering
The Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2012-2018: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading healthcare companies.
Learn More -
Global Cancer Vaccine Partnering 2012-2018: Deal trends, players, financials and forecasts
$2,995.00Publication date: Nov 2018 | Publisher: Current Partnering
The Global Cancer VaccinenPartnering 2012-2018: Deal trends, players, financials and forecasts provides comprehensive understanding and unprecedented access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.
Learn More -
Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2012-2018
$2,995.00Publication date: Nov 2018 | Publisher: Current Partnering
The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2012-2018 report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty asset purchase deals.
Learn More -
Global Option and Evaluation Deals in Pharma, Biotech and Diagnostics 2012-2018
$2,995.00Publication date: Nov 2018 | Publisher: Current Partnering
The Global Option and Evaluation Deals in Pharma, Biotech and Diagnostics 2012-2018 report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies.
Learn More -
Global Infectious Vaccines Partnering Terms and Agreements 2012 to 2018: Deal trends, players and financials
$2,995.00Publication date: Nov 2018 | Publisher: Current Partnering
The Global Infectious Vaccines Partnering Terms and Agreements 2012 to 2018: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the infectious vaccines partnering deals and agreements entered into by the worlds leading healthcare companies. Learn More -
Global Antibiotics Partnering Terms and Agreements 2010 to 2018
$2,995.00Publication date: Nov 2018 | Publisher: Current Partnering
The Global Antibiotics Partnering Terms and Agreements 2010 to 2018 report provides comprehensive understanding and unprecedented access to the antibiotic partnering deals and agreements entered into by the worlds leading healthcare companies.
Learn More -
Global Cancer Diagnostics Partnering 2012-2018: Deal trends, players, financials and forecasts
$2,995.00Publication date: Nov 2018 | Publisher: Current Partnering
The Global Cancer Diagnostics Partnering 2012-2018 report provides comprehensive understanding and unprecedented access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.
Learn More -
Global In Vitro Diagnostics Partnering 2012-2018: Deal trends, players, financials and forecasts
$2,995.00Publication date: Nov 2018 | Publisher: Current Partnering
Global In Vitro Diagnostics Partnering 2012-2018 report provides comprehensive understanding and unprecedented access to the in vitro diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.
Learn More
